Continuous administration of lenvatinib after first documented disease progression in patients with radioiodine-refractory thyroid cancer

Endocrine 2026

View at publisher
Authors: Naoki Fukuda, Jumpei Yoshida, Kazuhisa Toda, Xiaofei Wang, Ryosuke Oki, Takehiro Nakao, Tetsuya Urasaki, Kenji Nakano, Junichi Tomomatsu, Hiroki Mitani, Shunji Takahashi, Yuji Miura
DOI: 10.1007/s12020-026-04631-6
Cited by: 1
References: 31

Fields of Study & Subjects

Thyroid Cancer Diagnosis and Treatment Radiopharmaceutical Chemistry and Applications Thyroid Disorders and Treatments

Publication details

Journal / source
Endocrine
Publisher
Springer Science and Business Media LLC
Volume
91
Issue
1
Publication date
2 May 2026
Language
EN